pentobarbital will minimize the level or impact of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or influence of theophylline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will increase toxicity of ifosfamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. CYP3A4 inducers might increase the metabolism of ifosfamide to its Lively alkylating metabolites.
Comment: Barbiturates could enhance adverse effects, such as respiratory melancholy, made by harmful doses of TCAs. With therapeutic doses of TCAs, barbiturates increase metabolism and reduce blood concentrations of TCAs.
pentobarbital will reduce the level or influence of copyright topical by influencing hepatic enzyme CYP2B6 metabolism. Insignificant/Importance Unknown.
Check Closely (one)pentobarbital will reduce the level or effect of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. CYP3A4 inducers haven't been researched, coadministration not recommended by company
pentobarbital will minimize the extent or impact of verapamil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital boosts toxicity of methoxyflurane by expanding metabolism. Contraindicated. Amplified metabolism of methoxyflurane to nephrotoxic compounds.
pentobarbital will lessen the extent or influence of eltrombopag by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Observe.
pentobarbital will lower the level or effect of dexamethasone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the extent or outcome of cobimetinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay away from coadministration. Solid or average CYP3A inducers may decrease cobimetinib systemic exposure by >80% buy sodium pentobarbital without prescription and cut down its efficacy.
pentobarbital will lower the extent or impact of loratadine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lessen the extent or result of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Contraindicated (one)pentobarbital decreases amounts of vandetanib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Steer clear of coadministration with potent CYP3A4 inducers; these drugs reduce exposure to vandetanib by as much as forty%.